Post-transplantation diabetes mellitus: an overview

Sklyanik, Igor A.; Александрович, Скляник Игорь; Шамхалова, Минара Шамхаловна; Шамхаловна, Шамхалова Минара; Shestakova, Marina Vladimirovna; Владимировна, Шестакова Марина

doi:10.14341/dm2015220-31

Cited by 2 publications

(2 citation statements)

References 59 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Скрининг-тесты для выявления ПТСД целесообразно проводить после первого месяца трансплантации в течение первого года, когда пациенты достаточно стабильны и находятся на относительно постоянных дозах иммуносупрессивной терапии. Необходимо иметь в виду, что транзиторная гипергликемия, выявленная в первый месяц после трансплантации, согласно международным рекомендациям, не может служить критерием для постановки диагноза ПТСД, но является важным фактором риска развития ПТСД в первый год [33].…”

Section: трансплантация печениunclassified

Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features

Калмыкова

Кононенко

Mayorov

et al. 2019

Terapevticheskii arkhiv

View full text Add to dashboard Cite

Diabetes mellitus (DM) and chronic liver disease (CLD) are pathological conditions associated with each other and reaching epidemic proportions. There is a strong pathogenetic relationship of carbohydrate metabolism disorders and a number of CLD. Common mechanisms that provoke metabolic and autoimmune disorders in the development of various CLD, leading to steatosis, insulin resistance (IR), impaired glucose tolerance and the development of DM are described. Effective glycemic control can have a beneficial effect on the treatment of these patients, and, conversely, there is evidence of a positive effect of CLD therapy on carbohydrate metabolism. This review discusses the correction of carbohydrate metabolism in patients with CLD, the main groups of modern hypoglycemic drugs, mechanisms of their action, the impact on the physiology of the liver, the possibility of using each of these pharmacological groups in patients with impaired liver function. The modern approaches and possibilities of drug effects on the process of fibrogenesis in CLD, the effect of these drugs on carbohydrate metabolism are listed.

show abstract

Section: трансплантация печениunclassified

Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features

Калмыкова

Кононенко

Mayorov

et al. 2019

Terapevticheskii arkhiv

View full text Add to dashboard Cite

show abstract

“…The diseases caused by diabetes in a picture is represented in Fig. The signs of diabetes include frequent hunger, thirst, fatigue, changes in eyesight, persistent hunger, sudden weight loss, and the quick outflow of urine [12]. Diabetes can result in blindness, heart attacks, renal illness, lower limb amputations, and blindness if left untreated for an extended time.…”

Section: Introductionmentioning

confidence: 99%

Non-Invasive Glucose Measurement Technologies: Recent Advancements and Future Challenges

Jain,

Joshi,

Mohanty

et al. 2024

IEEE Access

View full text Add to dashboard Cite

Diabetes is a long-term condition in which a person's body cannot break down blood sugar adequately due to a shortage of insulin. The most crucial element of health care is continuously monitoring blood glucose (BG) levels. The main concern of effective glucose monitoring equipment is based on the blood-pricking technique. However, this may not be suggested for frequent glucose measurement. The paper presents various glucose-measuring technologies. The research discusses various non-invasive glucose measurement techniques and their management using advanced medical technologies. The configuration of the precise measuring device is essential to meet the blood glucose monitoring requirements that are not invasive systems. Non-invasive glucose monitoring devices solve the issue of frequently pricking patients for blood samples for clinical tests. For the goal of continuous health monitoring, a Smart Healthcare framework would be built on the Internet-of-Medical-Things (IoMT) and a Healthcare Cyber-Physical System (H-CPS) to estimate blood glucose. The study also discusses a few consumer devices and cutting-edge methods for measuring glucose. The paper also outlines the several difficulties and open challenges with glucose prediction.

show abstract

Post-transplantation diabetes mellitus: an overview

Cited by 2 publications

References 59 publications

Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features

Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features

Non-Invasive Glucose Measurement Technologies: Recent Advancements and Future Challenges

Contact Info

Product

Resources

About